Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

US approves new use for BMS’ Empliciti

pharmatimesNovember 08, 2018

Tag: BMS , Empliciti , pomalidomide

PharmaSources Customer Service